Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;11(2):126-30.
doi: 10.3969/j.issn.1671-5411.2014.02.012.

Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcome

Affiliations

Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcome

Gianluca Rigatelli et al. J Geriatr Cardiol. 2014 Jun.

Abstract

Objectives: To assess the impact on stent implantation rate and mid-term outcomes of prolonged high pressure angioplasty of femoropopliteal lesions.

Methods: We retrospectively enrolled 620 consecutive patients from January 2011 to December 2011 (75.6 ± 12.3 years, 355 males, 76.5% in Rutherford class 5-6), referred for critical limb ischemia and submitted to prolonged high-pressure angioplasty of femoropopliteal lesions. The definition of prolonged high-pressure angioplasty includes dilation to at least 18 atm for at least 120 s. Procedural data, and clinical and instrumental follow-up were analyzed to assess stent implantation rate and mid-term outcomes.

Results: The preferred approach was ipsilateral femoral antegrade in 433/620 patients (69.7%) and contralateral cross-over in 164/620 (26.4%) and popliteal retrograde + femoral antegrade in 23/620 (3.7%). Techniques included subintimal angioplasty in 427/620 patients (68.8%) and endoluminal angioplasty in 193/620 patients (31.2%). The prolonged high pressure balloon angioplasty procedure was successful in 86.2% (minor intra-procedural complications rate 15.7 %), stent implantation was performed in 74 patients (11.9%), with a significant improvement of ankle-brachial index (0.29 ± 0.6 vs. 0.88 ± 0.3, P < 00.1) and Rutherford class (5.3 ± 0.8 vs. 0.7 ± 1.9, P < 0.01), a primary patency rate of 86.7%, restenosis of 18.6 % on Doppler ultrasound and a target lesion revascularization of 14.8% at a mean follow-up of 18.1 ± 6.4 months (range 1-24 months). Secondary patency rate was 87.7%.

Conclusions: Prolonged high pressure angioplasty of femoropopliteal lesions appears to be safe and effective allowing for an acceptable patency and restenosis rates on mid-term.

Keywords: Angioplasty; Balloon; Peripheral artery disease; Stent.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Prolonged high-pressure angioplasty in a non calcified lesion.
(A): Baseline digital angiography in a 76-year old man with severe claudication demonstrating a long occlusion of the superficial femoral artery; (C): angiographic result after prolonged high pressure angioplasty with a Mustang balloon (B).
Figure 2
Figure 2. Prolonged high-pressure angioplasty in a severely calcified lesion.
(A-B): Baseline digital angiography in a 73-year old woman with severe coronary disease and ischemic heart cardiomyopathy and severe claudication demonstrating a long calcified occlusion of the superficial femoral and popliteal arteries; (E-F): angiographic result after prolonged high pressure angioplasty with a Dorado balloon (C-D).

Similar articles

Cited by

References

    1. BASIL trial investigators Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934. - PubMed
    1. Acin F, de Haro J, Bleda S, et al. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther. 2012;19:585–595. - PubMed
    1. Davaine JM, Quérat J, Guyomarch B, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg. 2013;46:201–212. - PubMed
    1. Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery) JACC Cardiovasc Interv. 2013;6:1295–1302. - PubMed
    1. Fusaro M, Cassese S, Ndrepepa G, et al. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol. 2013;168:4002–4009. - PubMed

LinkOut - more resources